In New Twist on VC Model, Texas’ Emergent Tech Opens Incubator for Portfolio Firms | GenomeWeb
In what may be a new life-sciences venture-capital model, Texas-based venture firm Emergent Technologies last week unveiled its own laboratory space in Austin for its portfolio biotech companies, and also revealed the first tenants of the new space.
 
In addition Emergent, which has been trawling the University of Texas system for its technologies, this week made available a $50,000 award to support proof-of-concept development of a selected technology developed by researchers in the UT system.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.